Skip to main content
HR 304 115th Congress House Health Drug trafficking and controlled substances Emergency medical services and trauma care Health information and medical records Health personnel Licensing and registrations

Protecting Patient Access to Emergency Medications Act of 2017

Introduced: January 5, 2017 Introduced by: Hudson, Richard Republican · North Carolina See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 24 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 17, 2017
Became Public Law No: 115-83.
Nov 17, 2017
Signed by President.
Nov 7, 2017
Presented to President.
Nov 2, 2017
Motion to reconsider laid on the table Agreed to without objection.
Nov 2, 2017
On motion that the House agree to the Senate amendment Agreed to without objection. (text as House agreed to Senate Amendment: CR H8421-8422)
Nov 2, 2017
Resolving differences -- House actions: On motion that the House agree to the Senate amendment Agreed to without objection.(text as House agreed to Senate Amendment: CR H8421-8422)
Nov 2, 2017
Mr. Hudson asked unanimous consent to take from the Speaker's table and agree to the Senate amendment. (consideration: CR H8421-8422)
Oct 25, 2017
Message on Senate action sent to the House.
Oct 24, 2017
Passed Senate with an amendment by Unanimous Consent.
Oct 24, 2017
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
Oct 24, 2017
Measure laid before Senate by unanimous consent. (consideration: CR S6773)
Oct 24, 2017
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
Jan 12, 2017
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Jan 10, 2017
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jan 9, 2017
Motion to reconsider laid on the table Agreed to without objection.
Jan 9, 2017
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 404 - 0 (Roll no. 25). (text: CR H206-207)
Jan 9, 2017
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 404 - 0 (Roll no. 25).(text: CR H206-207)
Jan 9, 2017
Considered as unfinished business. (consideration: CR H218)
Jan 9, 2017
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Jan 9, 2017
DEBATE - The House proceeded with forty minutes of debate on H.R. 304.
Jan 9, 2017
Considered under suspension of the rules. (consideration: CR H206-208)
Jan 9, 2017
Mr. Burgess moved to suspend the rules and pass the bill.
Jan 5, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 5, 2017
Introduced in House
 Votes taken on this bill 1
DateChamberWhat was voted onResultYes–No
Jan 10, 2017 House · vote #25 On Motion to Suspend the Rules and Pass Passed 404–0 See who voted →
 Plain-English summary Congressional Research Service

Protecting Patient Access to Emergency Medications Act of 2017

(Sec. 2) This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration (DEA) to register an emergency medical services (EMS) agency to administer controlled substances if the agency submits an application demonstrating that it is authorized to conduct such activity in the state in which the agency practices. The DEA may deny an application if it determines that the registration is inconsistent with the public interest.

An EMS agency may obtain a single registration in each state instead of a separate registration for each location.

A registered EMS agency may deliver, store, and receive controlled substances, subject to specified conditions.

An EMS professional of a registered EMS agency may administer controlled substances in schedules II, III, IV, or V outside the physical presence of a medical director if such administration is authorized under state law and pursuant to a standing or verbal order, subject to specified conditions.

The bill specifies that a hospital-based EMS agency (i.e., an EMS agency owned or operated by a hospital) may continue to administer controlled substances under the hospital's DEA registration.

What's happening now November 17, 2017

Became Public Law No: 115-83.

 Committees of jurisdiction 4
 Cosponsors 10
All 10 Democratic 5 Republican 5